Skip to main content
logo
Mayne Pharma Group Limited (MAYNF)
OTCMKTS · Delayed Price · Currency is USD
1.830
0.00 (0.00%)
At close: Feb 9, 2026

Mayne Pharma Group Revenue

In the fiscal year ending June 30, 2025, Mayne Pharma Group had annual revenue of 408.10M AUD with 5.07% growth. Mayne Pharma Group had revenue of 195.04M in the half year ending June 30, 2025.

Revenue
408.10M AUD
Revenue Growth
+5.07%
P/S Ratio
0.58
Revenue / Employee
831.15K AUD
Employees
491
Market Cap
153.87M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 2025408.10M19.70M5.07%
Jun 30, 2024388.40M204.81M111.56%
Jun 30, 2023183.59M26.44M16.82%
Jun 30, 2022157.15M-243.63M-60.79%
Jun 30, 2021400.78M-56.20M-12.30%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Zynex108.20M
China Medicine65.76M
PD-Rx Pharmaceuticals18.35M
Exlites Holdings International9.42M
Pharmagen4.41M
Gold Enterprise Group559.55K
Global Medical Products Holdings45.96K
DH Enchantment-42.87K
Revenue Rankings

Mayne Pharma Group News

More News